Market forecast: Sunny skies for contract manufacturers

Contract manufacturing is where it's at, at least through 2015. Global Industry Analysts projects a $41-billion market, thanks in part to the "huge number" of biotechs that lack production operations. The analysts expect demand for liquid dosage form services to rise six percent annually. Services for solid dosage forms are expected to be the largest segment. GIA release

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.